For the millions of people living with lupus – a chronic autoimmune disease that can damage the kidneys, brain and other ...

Johnson & Johnson has won U.S. Food and Drug Administration fast-track designation for its investigational nipocalimab drug in adults with systemic lupus erythematosus, a chronic autoimmune disease.

March is National Kidney Month, a time to shine a light on the thousands of individuals whose lives are deeply affected by ...

Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced that its abstract detailing clinical results ongoing Phase 1/2 trial ...

Johnson & Johnson’s (J&J) nipocalimab, a potential immunoselective investigational treatment for adults with systemic lupus ...

Autoimmune disease hair loss can happen with alopecia areata, lupus, thyroid diseases, rheumatoid arthritis, Crohn’s disease, and scalp psoriasis. Each disease has different effects, ...

A new study examined whether urinary biomarkers could predict future kidney complications in individuals with lupus nephritis ...

Acute kidney injury (AKI) in patients with lupus nephritis is tied with rapid disease worsening and potential progression to chronic kidney disease and kidney failure.

Lupus is an autoimmune disease; the body’s immune system attacks healthy cells leading to pain, fever, rashes, organ damage and other symptoms. The Lupus Foundation of America estimates more than 5 ...

The FDA grants Fast Track designation to nipocalimab for SLE, following positive results from the phase 2b JASMINE trial.

NORFOLK, Va. — You’ve likely heard of lupus, but do you know what it is? It is an autoimmune disorder that’s difficult to describe, diagnose and treat. Lupus is one of those diseases you can’t often ...

Scientists may have pinpointed a primary cause of lupus, a chronic autoimmune disease. Researchers from Northwestern Medicine in Chicago and Brigham and Women’s Hospital in Boston claim they have ...